help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roemmich, J. N.
Right arrow Articles by Rogol, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roemmich, J. N.
Right arrow Articles by Rogol, A. D.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 5 1440-1447
Copyright © 1998 by The Endocrine Society


Original Studies

Alterations in Growth and Body Composition During Puberty: III. Influence of Maturation, Gender, Body Composition, Fat Distribution, Aerobic Fitness, and Energy Expenditure on Nocturnal Growth Hormone Release1

James N. Roemmich, Pamela A. Clark, Vu Mai, Stuart S. Berr, Arthur Weltman, Johannes D. Veldhuis and Alan D. Rogol

University of Virginia Health Sciences Center, Department of Pediatrics, Division of Endocrinology (J.N.R., P.A.C., A.D.R.); Department of Radiology (V.M., S.S.B.); Department of Medicine, Division of Endocrinology and Metabolism (A.W., J.D.V.); Department of Pharmacology (A.D.R.); and University of Virginia, Curry School of Education (A.W.), Charlottesville, Virginia 22908

Address all correspondence and requests for reprints to: James N. Roemmich, University of Virginia Health Sciences Center, Department of Pediatrics, Division of Endocrinology, Box 386, Charlottesville, Virginia 22908. E-mail: jr5n{at}virginia.edu


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
We examined the relationships among gender, sexual maturation, four-compartment model estimates of body composition, body fat distribution (magnetic resonance imaging for abdominal visceral fat and anthropometrics), aerobic fitness, basal and total energy expenditure, and overnight GH release in an ultrasensitive chemiluminescence assay in healthy prepubertal and pubertal boys (n = 18 and 11, respectively) and girls (n = 12 and 18, respectively). Blood samples were withdrawn every 10 min from 1800–0600 h to determine the area under the serum GH-time curve (AUC), sum of the GH peak heights ({Sigma} GH peak heights), and the mean nadir GH concentration. GH release was greater in the pubertal than prepubertal subjects due to an increase in {Sigma} GH peak heights (43.8 ± 3.6 vs. 24.1 ± 3.5 ng·mL-1, P = 0.0002) and mean nadir (1.7 ± 0.2 vs. 0.7 ± 0.2 ng·mL-1, P = 0.0002), but not peak number (4.3 ± 0.2 vs. 4.5 ± 0.2). The girls had a greater {Sigma} GH peak heights (39.0 ± 3.5 vs. 28.8 ± 3.6 ng·mL-1, P = 0.05) and mean nadir concentration (1.4 ± 0.2 vs. 0.9 ± 0.2 ng·mL-1, P = 0.05) than the boys. Significant inverse relationships existed between {Sigma} GH peak heights (r = -0.35, P = 0.06) or mean nadir (r = -0.39, P = 0.04) and four-compartment percent body fat for all boys but not for all girls or when combining all subjects. For all girls, significant inverse relationships existed between {Sigma} GH peak heights (r = -0.39, P = 0.03) or mean nadir (r = -0.37, P = 0.04) and waist/hip ratio. Similar inverse relationships in all boys or all subjects were not significant. Forward stepwise regression analysis determined that bone age (i.e. maturation, primary factor) and gender were the significant predictors of AUC, {Sigma} GH peak heights, and mean nadir. The influence of maturation reflects rising sex steroid concentrations, and the gender differences appear to be because of differences in estradiol concentrations rather than to body composition or body fat distribution.


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
APPROPRIATE GH release during childhood and adolescence may help optimize lean tissue and limit the formation of fat in the abdominal visceral depot (1, 2). In the adult, abdominal visceral fat (AVF) has been linked to metabolic complications including hyperlipidemia, insulin resistance, and type II diabetes mellitus (1, 3). GH-deficient children and adults have an increase in size of the abdominal subcutaneous fat and AVF depots (4, 5, 6), that are reduced with GH therapy (2, 4). GH therapy may produce a redistribution of subcutaneous adipose tissue from abdominal to peripheral sites (7), although this finding is not uniform (8). In healthy adults GH release is inversely related to the size of the visceral adipose depot (6, 9), but a similar relationship has not been investigated in healthy children.

The relationship between total body composition and GH release in children and adolescents is unclear. Some investigations have found inverse relationships between the body mass index and GH release (10, 11), whereas others have not (12). Still others have found that the relationship is significant only in pubertal girls (13). The confusion may be due, in part, to the use of the body mass index, a crude marker of adiposity that is especially difficult to interpret during growth because weight changes relative to height consist of increases in fat and lean tissue (14). We have shown that valid estimates of body composition in children and adolescents require the use of a multicompartment model of body composition that corrects for the proportional water content of the fat-free mass (FFM) (15).

GH therapy increases energy expenditure in children (16, 17) and adults (18, 19, 20), but when the increase in energy expenditure was corrected for the increase in metabolically active FFM, accurate measures of body composition were not used (16, 20). We are unaware of published studies clarifying the relationship between energy expenditure and endogenous GH release in children and adolescents. Although aerobic fitness and exercise training enhance GH release in adults (6, 21, 22, 23), the same relationships have not been studied in children. Whereas gender differences in these and other attributes may be prominent in the adult (24), sex differences in body composition and in the GH axis are less well studied before and during adolescence. We hypothesized that the GH release of healthy prepubertal and pubertal boys and girls would be more highly related to the amount of AVF than to criterion estimates of percentage body fat and directly related to aerobic fitness and energy expenditure.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Subjects

Prepubertal boys (n = 18), pubertal boys (n = 11), prepubertal girls (n = 12), and pubertal girls (n = 18) were evaluated in a cross-sectional manner. Subjects were placed into pubertal groups based on the stage of secondary sex characteristics as assessed by the method of Tanner (25). Informed consent was obtained from a parent and assent from each child before entrance into the study. Using a triceps skinfold thickness of greater than the 85th percentile as a cutoff, three of the prepubertal boys and two of the pubertal girls were classified as obese. Bone age was determined by the Fels method (26) by an experienced assessor (J.N.R.).

Blood sampling and hormone assays

After the patients’ admission to the General Clinical Research Center at 0800 h, a catheter was inserted into a forearm vein at 1600 h and kept patent with a heparin lock. Serial blood sampling (every 10 min) was initiated at 1800 h and continued until 0600 h. Activity was limited to watching television, reading, and walking, and the subjects had to remain in bed with the lights out after 2200 h. Starting with breakfast, the subjects consumed meals and snacks constant for energy, fat (30% of calories), protein (15% of calories), and carbohydrate (55% of calories) at standard times. The Nichols Luma Tag human GH chemiluminescence assay (San Juan Capistrano, CA) was used to measure the serum GH concentrations. Use of the assay has been previously described (27). The sensitivity of the assay is 0.002 µg/L. The intraassay coefficients of variation (CVs) are 4.9% at 0.2 µg/L, 6.7% at 2 µg/L, and 6.4% at 4.9 µg/L whereas the interassay CVs were 7.2% at both 1.7 µg/L and 4.2 µg/L (28). GH pulse characteristics were assessed by the model-free Cluster algorithm version 6.01 (29).

Serum total testosterone concentration in the 0600-h blood sample was measured by RIA using kits from Diagnostic Products Corp. (Los Angeles, CA). The sensitivity of the testosterone assay was 10.0 ng·dL-1 with an intraassay CV of 5–6% within the range of 100–800 ng·dL-1. The interassay CV ranged from 9.2–12.9% within the range of 70–840 ng·dL-1. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) concentrations were measured by RIA (Nichols Institute, San Juan Capistrano, CA). IGF-I concentrations were measured after acid-ethanol extraction and had an intraassay CV of 2.4% and 3.0% at 0.53 ng·mL-1 and 0.92 ng·mL-1, respectively, and an interassay CV of 5.2% and 8.4% at 0.54 ng·mL-1 and 0.82 ng·mL-1, respectively. The sensitivity was 0.06 ng·mL-1. For the IGFBP-3 assay, the intraassay CV ranged from 7.3% at 0.17 µg·mL-1 to 3.8% at 3.08 µg·mL-1, and the interassay CV ranged from 5.3% at 0.60 µg·mL-1 to 6.3% at 31.69 µg·mL-1. The sensitivity was 0.038 µg·mL-1.

Body composition

Body composition was estimated using the four-compartment model of Lohman (14). We recently described and validated the use of this model in children and adolescents (15). In this model, body density is measured by underwater weighing and corrected for residual lung volume by nitrogen washout, total body water by deuterium oxide dilution, and bone mineral content by dual-energy X-ray absorptiometry (15).

Anthropometry

A trained anthropometrist (J.N.R.) completed all measures. Height, waist girth, hip girth, trunk skinfolds (subscapular, chest, midaxillary, suprailliac, and abdominal) and peripheral skinfolds (triceps, biceps, thigh, and medial calf) were measured as recommended by Lohman et al. (30).

Magnetic resonance imaging (MRI)

Subcutaneous and visceral fat areas at the level of the L4-L5 intervertebral space were measured with MRI using a Siemens Vision 1.5T scanner (Islan, NJ). A T1 weighted spin-echo saggital scout scan with a repetition of 500 msec, echo time (TE) of 20 msec, 10-mm slice thickness with a 10-mm gap, 128 x 256 matrix, and two signal averages was used to locate the L4-L5 disk space. Adipose tissue at the L4-L5 levels was assessed using a Dixon imaging sequence phase corrected for magnetic field inhomogeneities. A standard spin-echo pulse sequence was used for the in-phase image. The out-of-phase image was acquired by shifting the 180 degrees refocusing pulse by 1.12 ms. Images were acquired with a slice thickness of 6 mm, matrix of 256 x 256, and TR/TE of 575/15 ms. No oversampling or raw filters were used in the data acquisition, and two acquisitions were used per slice. The images were acquired with 100% gap, followed by a shift in slices that led to a set of contiguous two-dimensional images. For postacquisition processing, a magnetic field inhomogeneity map was calculated from the in-phase and out-of-phase images as previously described (31), which assumes that there are unequal amounts of fat and water in each pixel. This map was then used to unwrap phase shifts induced by the inhomogeneities using a region-growing technique, and used to correct for phase error in the opposed phase image (32). Adding or subtracting the in-phase and opposed phase images resulted in the water and fat images, respectively. The fat- and water-based tissue areas were determined using MedX Software (Sensor Systems, Sterling, VA).

Energy expenditure

The basal metabolic rate (BMR) was measured for 30 min via indirect calorimetry (Deltatrac, SensorMedics, Yorba Linda, CA). Subjects were assessed on waking after the overnight blood sampling at the General Clinical Research Center. To measure the total energy expenditure (TEE) subjects consumed an oral dose of 2H2O (0.5 g•kg-1) and H218O (1.5 g•kg-1). Urine samples were collected at baseline, 4 h, and 5 h, and at 1, 6, and 12 days after dosing. All urine samples were collected between 0800 and 1200 h. The samples were kept frozen at -20 C in cryovials until analysis by isotope ratio mass spectroscopy (Metabolic Solutions, Merrimack, NH). Differences in 2H and 18O in the pre- and postdose urine samples were determined using the unprocessed mass spectrometric data as previously described (33). Linear regression was used to determine the slope and intercept of the relationship between baseline and the normalized isotope 2H and 18O data. The pool sizes for 2H2O (ND) and H218O (NO) were the reciprocals of the intercepts. The intercept of the regression line was the ND/NO ratio. The fractional turnover rates of 2H (kD) and 18O (kO) were determined from the slope of the regression line. The mean daily rate of CO2 production (rCO2, mol•day-1) was calculated by the revised equations of Speakman et al. (34). The mean daily energy expenditure was calculated by multiplying the rCO2 value by 127.5 kcal·mol-1 CO2, the energy equivalent of the typical Western diet.

Peak oxygen consumption (VO2 peak)

VO2 peak was measured using a treadmill (Quinton Q65, Seattle, WA) exercise test. After a walking warm-up, the subjects began at an initial velocity of 3.4–6 mph depending on the size of the child. The initial velocity was then held constant, and the grade was increased from 0 by 2.5% every 2 min until volitional exhaustion. Metabolic data were collected every 20 s during the exercise bout via standard indirect calorimetry procedures using a SensorMedics 2700-Z metabolic cart (Yorba Linda, CA). Heart rates were monitored by echocardiograph. Subjects were given verbal encouragement throughout the test.

Statistical analyses

Group differences in body composition, body fat distribution, energy expenditure, aerobic fitness, serum hormone concentrations, and nocturnal GH pulse characteristics were tested with two-way ANOVA [(2) gender x (2) maturation]. Linear regression analysis was used to examine the strength of the relationship between GH pulse attributes and serum testosterone, body composition, body fat distribution, VO2 peak, and energy expenditure variables. Multiple linear regression was employed to correct the relationship between energy expenditure and GH release for the FFM. Forward stepwise regression was used to determine the combination of variables that most accurately predicted GH area under the curve (AUC), sum of the GH peak heights ({Sigma} GH peak heights), and mean nadir GH concentration with attention to multicolinearity between variables. A maximum of two steps was examined to maintain an adequate subject-to-predictor ratio (35).


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The pubertal subjects had a greater bone age (P < 0.0001), height (P < 0.0001), weight (P < 0.0001), fat mass (FM, P = 0.009), AVF (P = 0.02), waist girth (P < 0.0001), BMR (P < 0.0001), and TEE (P = 0.008) (Table 1Go). The maturation effect for waist/hip circumference (W:H) was P = 0.08. The males had a lower percentage body fat (%BF, P = 0.0005), FM (P = 0.02), and sum of skinfolds (P = 0.05) and a greater height (P = 0.02) and BMR (P = 0.01) than the females. There was an interaction for FFM (P = 0.05) and VO2 peak (P = 0.05), because the pubertal boys had a greater FFM and VO2 peak than the pubertal girls did.


View this table:
[in this window]
[in a new window]
 
Table 1. Physical characteristics, four-compartment model body composition, body fat distribution, sum of skinfolds, energy expenditure, and aerobic fitness of the subject groups

 
The 12-h GH pulse characteristics, serum IGF-I and IGFBP-3 concentrations, and serum testosterone concentrations are shown in Table 2Go. The pubertal subjects had a greater AUC (P < 0.0001), mean nadir GH concentration (P = 0.0002), {Sigma} GH peak heights (P = 0.0002), IGF-I (P < 0.0001), and IGFBP-3 (P = 0.007) concentrations. The girls had a greater mean nadir GH concentration (P = 0.04) and {Sigma} GH peak heights (P = 0.05) than the males. The pubertal boys had greater testosterone concentrations than the other groups (gender by maturation interaction: P < 0.0001).


View this table:
[in this window]
[in a new window]
 
Table 2. Twelve-hour nocturnal serum GH pulse characteristics, serum IGF-I, and IGFBP-3 concentrations, and testosterone concentrations of subject groups

 
The AUC was directly related to the mean nadir serum GH concentration (r = 0.71, P < 0.0001) and the {Sigma} GH peak heights (r = 0.83, P < 0.0001), but not to the GH peak number (r = -0.13, P = 0.34) or the peak interval (r = 0.14, P = 0.29) (data not shown). Serum testosterone concentration was directly related to GH pulse parameters of the boys (Table 3Go).


View this table:
[in this window]
[in a new window]
 
Table 3. Correlation coefficients of GH pulse parameters with testosterone concentration

 
The relationships between four-compartment estimated %BF and GH pulse parameters are shown in Fig. 1Go. The AUC was not related to %BF for any subject group. The inverse relationships between %BF and {Sigma} GH peak heights and mean nadir GH concentration were stronger for the boys than for the girls or all subjects combined. As shown in Fig. 2Go, there were only weak direct relationships between the AVF and GH pulse characteristics. The waist circumference and VO2 peak were not related to GH pulse characteristics. In the boys, modest correlations were found between the sum of skinfolds and AUC (r = -0.31, P = 0.11), {Sigma} GH peak heights (r = -0.30, P = 0.11), and mean nadir (r = -0.30, P = 0.11). The W:H was inversely related to all three pulse characteristics for all subjects and for the {Sigma} GH peak heights and mean nadir in the girls (Fig. 3Go).



View larger version (27K):
[in this window]
[in a new window]
 
Figure 1. Relationship between four-compartment estimated percentage body fat and serum GH vs. time AUC (upper panel), {Sigma} GH peak heights (middle panel), and mean nadir GH concentration (lower panel). •, Prepubertal boys; {blacktriangleup}, pubertal boys; {circ}, prepubertal girls; {triangleup} pubertal girls.

 


View larger version (25K):
[in this window]
[in a new window]
 
Figure 2. Relationship between abdominal visceral fat area and GH vs. time AUC (upper panel), {Sigma} of GH peak heights (middle panel), and mean nadir GH concentration (lower panel). •, Prepubertal boys; {blacktriangleup}, pubertal boys; {circ}, prepubertal girls; {triangleup} pubertal girls.

 


View larger version (27K):
[in this window]
[in a new window]
 
Figure 3. Relationship between W:H and GH vs. time AUC (upper panel), {Sigma} of GH peak heights (middle panel), and mean nadir GH concentration (lower panel). •, Prepubertal boys; {blacktriangleup}, pubertal boys; {circ} prepubertal girls; {triangleup}, pubertal girls.

 
The BMR was directly related to the AUC for all subjects (r = 0.33, P = 0.01) and for all girls (r = 0.57, P = 0.001) and the {Sigma} GH peak heights for all girls (r = 0.37, P = 0.04). There was a modest relationship between BMR and AUC (r = 0.32, P = 0.09) in the boys. The TEE was related to the AUC (r = 0.48, P < 0.05) and {Sigma} GH peak heights (r = 0.43, P < 0.05) for all girls, but not all boys. The only relationship to be maintained after correcting the BMR and TEE for the four-compartment estimated FFM was that between the AUC and BMR in the girls (Table 4Go).


View this table:
[in this window]
[in a new window]
 
Table 4. Results from multiple linear regression analyses using GH concentration vs. time AUC of all girls as dependent variable

 
Forward stepwise regression (Table 5Go) showed that bone age (maturation) was the primary variable influencing AUC, whereas gender was a secondary predictor. For {Sigma} GH peak heights, bone age emerged as the strongest predictor and W:H as a weaker predictor. The W:H (P = 0.006) and bone age (P = 0.07) contributed in the stepwise regression to predict the mean nadir. We also ran the forward stepwise regressions without W:H as an independent variable because of the potential spurious results caused by the use of ratios in statistical analyses (36). When W:H was excluded, bone age and gender were the primary and secondary predictors of all three pulse attributes, respectively (Table 6Go).


View this table:
[in this window]
[in a new window]
 
Table 5. Results of forward stepwise regression analyses using GH vs. time AUC, {sum} GH peak heights, and mean nadir GH concentration as the dependent variables. Only those variables that accounted for a significant amount of variance in dependent variable are shown.

 

View this table:
[in this window]
[in a new window]
 
Table 6. Results of forward stepwise regression analyses using GH vs. time AUC, {sum} GH peak heights, and mean nadir GH concentration as the dependent variables. W:H circumference was excluded as an independent variable because it is a ratio and may produce spurious statistical results.

 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
We investigated the relationships among criterion measures of body composition, body fat distribution, energy expenditure, aerobic fitness, and GH release in children and adolescents. The use of multicompartment criterion measures of body composition and GH release to study the relationship between adiposity and GH release is required because estimates from underwater weighing, dual-energy x-ray absorptiometry, bioelectrical impedance, and skinfold thicknesses may not be valid in children and adolescents, because the above methods do not correctly account for the lower-than-assumed density of the FFM of children (15). Furthermore, less-sensitive measures of GH than our ultrasensitive GH assay underestimate GH concentration over time (27, 28).

As shown previously (11, 12, 13), pubescents have a greater nocturnal GH release (AUC) than prepubescents because of an increase in the {Sigma} GH peak heights and mean nadir GH concentration, rather than number of GH peaks (Table 2Go). Our use of a sensitive chemiluminescent GH assay has permitted detection of a pubertal elevation in nadir GH concentration in boys as has been previously reported in girls (10). Pubertal elevations in GH have been attributed, in part, to concurrent elevations in sex steroid concentrations (37, 38, 39), particularly estrogen (40), which in the male is primarily derived from testosterone via aromatization (40, 41). We found that the testosterone concentration was directly related to GH release in the boys (Table 3Go).

There are also gender differences in GH release, because girls have a greater {Sigma} GH peak heights (P = 0.05) and mean nadir (P = 0.04) than boys (Table 2Go). Women also have greater GH release than men because of a greater GH pulse mass, which has been attributed to estrogen (42, 43). Estradiol concentrations are not reported here because several of the prepubertal girls had estradiol concentrations below the sensitivity of the assay, and in the pubertal girls, a single blood sample to determine estradiol concentrations is of limited utility because it is influenced by the phase of the menstrual cycle. The nonregular menstrual period length of pubescent girls and the occurrence of menstrual cycles without menstrual bleeding make it difficult to determine the girls’ menstrual phase when they are studied.

Few data are available concerning the relationship between endogenous GH release and energy expenditure in children and adolescents. Both the quantity of metabolically active tissue (FFM) and release of GH increase during puberty, requiring correction for the FFM. After a regression-based correction technique, the AUC was still related to the BMR in girls. Thus, the FFM cannot totally account for the direct relationship between GH release and energy expenditure. GH is thought to increase the BMR, in part, by increasing the conversion of T4 to the more metabolically active T3 (20).

We found that there were modest inverse relationships between our accurate four-compartment model-estimated %BF and pulsatile GH release ({Sigma} GH peak heights) and basal GH release (mean nadir) in the boys (Fig. 1Go). These data suggest that general adiposity affects GH release (or vice versa) more in boys than in girls. That the basal GH concentrations were more highly related to body composition than the peak values agrees with the data of Hindmarsh et al. (44). Although we do not yet know the precise role of various pulse attributes in the interaction with body composition, there is evidence that the peak GH concentration and the nadir concentration may impart different metabolic signals and gene responses to the target tissues in humans (45, 46) and rodents (47, 48).

The W:H was also inversely related to GH release (Fig. 3Go) but the relationships were much stronger in the girls than in the boys. Currently, we do not know what the W:H is a marker of in children and youth. Although others have shown that the W:H is highly related to AVF in adults (49), we found that the W:H was not related to either the AVF (r = 0.03, P = 0.84) or the %BF (r = 0.05, P = 0.72) (data not shown). The W:H is generally thought to be a marker of abdominal fat distribution (50). Our data suggest that those girls with a more android distribution of abdominal fat have lesser amounts of GH released during pulses and a lower nadir GH concentration, which corresponds to our finding of a lower sum of peak heights and mean nadir for GH release in boys than girls (Table 2Go).

Interestingly, other measures of fat distribution; abdominal visceral adipose tissue (Fig. 2Go), abdominal subcutaneous adipose tissue, waist girth, and sum of skinfolds (a marker of total subcutaneous fat) were not so strongly related to the GH release parameters (Table 3Go), as was the W:H. In adults, visceral adipose tissue is the primary negative determinant affecting neruosecretory activity of the GH axis (6, 9, 51). The lack of relationship in youth is probably because of increases in both the AVF and GH release during puberty (Tables 1Go and 2Go). This may explain why we found weak positive relationships between AVF and GH release parameters, whereas others have found inverse relationships in adults (6, 9, 51). We contend that because of the overriding effects of puberty to increase sex steroid and GH release, despite concomitant increases in FM and AVF, the relationship between AVF and GH release is not apparent by the current criterion methods and may not become apparent until early adulthood. In addition, a critical amount of visceral fat (130 cm2), found in only one of our subjects, may be necessary before the effects on the GH axis are evident (49).

Although body composition and energy expenditure were related to GH release, forward stepwise regression showed that maturation, gender, and the W:H could best predict the various GH pulse attributes (Table 5Go). Bone age (maturation) was a common factor in predicting all three pulse attributes, and the primary factor influencing AUC and {Sigma} GH peak heights. The secondary factor for AUC was gender, suggesting that the total nocturnal GH release depends most on the pubertal status and gender. As discussed above, the greater total nocturnal GH release during puberty and in girls compared with boys is thought to be because of differences in sex steroid (mainly estrogen) concentrations. The secondary factor influencing the {Sigma} GH peak heights is W:H, because the more android the distribution of abdominal fat, the smaller the GH peak heights. This would partially account for the males having smaller {Sigma} GH peak heights than the females (Table 2Go). However, the inverse relationship between W:H and the size of the GH peak heights was strongest in the females. The W:H was the primary predictor of the mean nadir GH concentration, suggesting that nadir GH concentrations may influence body fat distribution and metabolism (or vice versa). Other studies suggest that low basal concentrations of GH have an important metabolic effect in the human including increased lipolysis (45).

However, the use of ratios, such as the W:H, in statistical analyses can produce spurious results and should be interpreted with caution (36). When the forward stepwise regression analyses were completed and W:H was omitted as an independent variable, bone age and gender were the only variables that were related to the various GH pulse parameters (Table 6Go). These results support our theory that during puberty, the maturation process and gender override the influence of body composition and body fat distribution on GH release.

In conclusion, girls had greater GH release than boys despite the former’s greater FM and %BF. Thus, in children and adolescents additional factors, such as the general state of maturation, gender, and sex steroids are more important than the absolute body composition or body fat distribution for modulating GH release. Forward stepwise regression analysis showed that maturation (bone age) and gender were the primary determinants of total nocturnal GH release, {Sigma} GH peak heights, and mean nadir GH concentration.


    Acknowledgments
 
We are indebted to Ms. Sandra Jackson and the nursing staff at the University of Virginia General Clinical Research Center who provided patient care; Judy Weltman, M.S., and Laurie Wideman, Ph.D., for collecting the VO2 peak and basal metabolic rate data; Milagros Huerta, M.D., Ms. Kendra Dolan, and Mr. Rahib Poonawala for their assistance with data collection; and John Christopher for his help with the MRI methodology. We also acknowledge the subjects for their enthusiasm for the research program for the past 2 yr.


    Footnotes
 
1 This work was supported in part by grants from the National Institutes of Health HD 32631 (to A.D.R.) and AG147991 (to J.D.V.), General Clinical Research Center Grant MO1 RR00847 (to the University of Virginia), Genentech Foundation (to P.A.C.), and the University of Virginia Children’s Medical Center (to J.N.R.). Back

Received October 2, 1997.

Revised January 8, 1998.

Accepted January 15, 1998.


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Johannsson G, Marin P, Lonn L, et al. 1997 Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab. 82:727–734.[Abstract/Free Full Text]
  2. Snel YEM, Brummer R-JM, Doerga ME, et al. 1995 Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects. Am J Clin Nutr. 61:1290–1294.[Abstract/Free Full Text]
  3. Ronnemaa T, Koskenvuo M, Marniemi J, et al. 1997 Glucose metabolism in identical twins discordant for obesity. The critical role of visceral fat. J Clin Endocrinol Metab. 82:383–387.[Abstract/Free Full Text]
  4. De Boer H, Blok G-J, Voerman B, Derriks P, van der Veen E. 1996 Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men. Int J Obesity. 20:580–587.
  5. Bengtsson B-A, Brummer R-JM, Eden S, Rosen T, Sjostrom L. 1992 Effects of growth hormone on fat mass and fat distribution. Acta Paediatr Suppl. 383:62–65.[Medline]
  6. Vahl N, Jorgensen JOL, Jurik AG, Christiansen JS. 1996 Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab. 81:2209–2215.[Abstract]
  7. Rosenbaum M, Gertner JM, Leibel RL. 1989 Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab. 69:1274–1281.[Abstract/Free Full Text]
  8. Wit JM, van’t Hof MA, van den Brande JL. 1988 The effect of human growth hormone therapy on skinfold thickness in growth hormone-deficient children. Eur J Pediat. 147:588–592.[CrossRef][Medline]
  9. Vahl N, Jorgensen JOL, Skjaerbaek C, Veldhuis JD, Orskov H, Christiansen JS. 1997 Abdominal adiposity rather than age and sex predicts the mass and patterned regularity of growth hormone secretion in mid-life healthy adults. Am J Physiol. 272:E1108–E1116.
  10. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T. 1994 Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab. 78:1195–1201.[Abstract]
  11. Martha PM, Gorman KM, Blizzard RM, Rogol AD, Veldhuis JD. 1992 Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass. J Clin Endocrinol Metab. 74:336–344.[Abstract]
  12. Costin G, Kaufman FR, Brasel JA. 1989 Growth hormone secretory dynamics in subjects with normal stature. J Pediatr. 115:537–544.[CrossRef][Medline]
  13. Rose SR, Municchi G, Barnes KM, et al. 1991 Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab. 73:428–435.[Abstract/Free Full Text]
  14. Lohman TG. 1992 Advances in Body Composition Assessment. Champaign, IL; Human Kinetics: pp 7–23.
  15. Roemmich JN, Clark PA, Weltman A, Rogol AD. 1997 Alterations in growth and body composition during puberty: I. Comparing multicompartment body composition models. J Appl Physiol. 83:927–935.[Abstract/Free Full Text]
  16. Gregory JW, Greene SA, Jung RT, Scrimgeour CM, Rennie MJ. 1993 Metabolic effects of growth hormone treatment: an early predictor of growth response. Arch Dis Child. 68:205–209.[Abstract/Free Full Text]
  17. Vaisman N, Zadik Z, Akivias A, et al. 1994 Changes in body composition, resting energy expenditure, and thermic effect of food in short children on growth hormone therapy. Metabolism. 43:1543–1548.[CrossRef][Medline]
  18. Chong PKK, Jung RT, Scrimgeour CM, Rennie MJ, Paterson CR. 1994 Energy expenditure and body composition in growth hormone deficient adults on exogenous growth hormone. Clin Endocrinol (Oxf). 40:103–110.[Medline]
  19. Stenlof K, Johansson J-O, Lonn L, Sjostrom L, Bengtsson B-A. 1997 Diurnal variations in twenty-four-hour energy expenditure during growth hormone treatment of adults with pituitary deficiency. J Clin Endocrinol Metab. 82:1255–1260.[Abstract/Free Full Text]
  20. Wolthers T, Grofte T, Moller N, et al. 1996 Calorigenic effects of growth hormone: the role of thyroid hormones. J Clin Endocrinol Metab. 81:1416–1419.[Abstract]
  21. Roemmich JN, Rogol AD. 1997 Exercise and growth hormone: does one affect the other? J Pediatr. 131:S75–S80.
  22. Weltman A, Weltman JY, Schurrer R, Evans WS, Veldhuis JD, Rogol AD. 1992 Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity. J Appl Physiol. 72:2188–2196.[Abstract/Free Full Text]
  23. Weltman A, Weltman JY, Hartman ML, et al. 1994 Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender J Clin Endocrinol Metab. 78:543–548.[Abstract]
  24. Veldhuis JD. 1997 Gender differences in secretory activity of the human somatotropic (GH) axis. Eur J Endocrinol. 134:287–295.
  25. Tanner J.M. 1962 Growth at adolescence. Oxford: Blackwell Scientific Publications.
  26. Roche AF, Chumlea Wm C, Thissen D. 1988 Assessing the skeletal maturity of the hand-wrist: Fels method. Springfield, IL: Charles C Thomas.
  27. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab. 78:1312–1319.[Abstract]
  28. Chapman IM, Bach MA, Van Cauter E, et al. 1996 Stimulation of growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-667) in healthy elderly subjects. J Clin Endocrinol Metab. 81:4249–57.[Abstract]
  29. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile, and robust algorithm for endocrine detection. Am J Physiol. 250:E486–E493.
  30. Lohman TG, Roche AF, Martorell R. 1988 Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books; pp 55–70.
  31. Coombs BD, Szumowski J, Coshow W. 1995 Society for Magnetic Resonance, 3rd Annual Meeting, Nice, France, Book of Abstracts, 647 (Abstract).
  32. Szumowski J, Coshow WR, Li F, Quinn SF. 1994 Phase unwrapping in the three-point Dixon method for fat suppression MR imaging. Radiology. 192:555–561.[Abstract/Free Full Text]
  33. International Atomic Energy Agency. 1990 A.M. Prentice, ed. The doubly-labeled water method for measuring energy expenditure: technical recommendations for use in humans.Vienna: NAHRES-4.
  34. Speakman JR, Sreekumaran Nair K, Goran MI. 1993 Revised equations for calculating CO2 production from doubly labeled water in humans. Am J Physiol. 264:E912–E917.
  35. Thomas JR, Nelson JK. 1990 Research Methods in Physical Activity, 2nd ed. Champaign, IL: Human Kinetics; 126–127.
  36. Allison DB, Paultre F, Goran MI, Poehlman ET, Heymsfield SB. 1995 Statistical considerations regarding the use of ratios to adjust data. Int J Obesity. 19:644–652.[Medline]
  37. Mauras N, Rogol AD, Veldhuis JD. 1989 Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner’s syndrome. J Clin Endocrinol Metab. 69:1053–1058.[Abstract/Free Full Text]
  38. Giustina A, Scalvini T, Tassi C, et al. 1997 Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocrinol Metab. 82:1210–1219.[Abstract/Free Full Text]
  39. Link K, Blizzard RM, Evans WS, Kaiser DL, Parker MW, Rogol AD. 1986 The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males. J Clin Endocrinol Metab. 62:159–164.[Abstract/Free Full Text]
  40. Metzger DL, Kerrigan JD. 1994 Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence. J Clin Endocrinol Metab. 79:513–518.[Abstract]
  41. Veldhuis JD, Metzger DL, Martha Jr PM, et al. 1997 Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (GH)-IGF-I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab. 82:3414–3420.[Abstract/Free Full Text]
  42. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51–58.[Abstract/Free Full Text]
  43. Van den Berg G, Veldhuis JD, Frolich M, Roelfsema F. 1996 An amplitude-specific divergence in the pulsatile mode of GH secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab. 81:2460–2466.[Abstract]
  44. Hindmarsh PC, Fall CHD, Pringle PJ, Osmond C, Brook CGD. 1997 Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters. J Clin Endocrinol Metab. 82:2172–2176.[Abstract/Free Full Text]
  45. Jorgensen JO, Moller J, Alberti KG, Schmitz O, Christiansen JS, Orskov H, Moller N. 1993 Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and health untreated subjects. J Clin Endocrinol Metab. 77:1589–1596.[Abstract]
  46. Moller N, Moller J, Jorgensen JO, Ovesen P, Schmitz O, Alberti KG, Christiansen JS. 1993 Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans. Clin Endocrinol (Oxf). 39:577–581.[Medline]
  47. Ram PA, Park SH, Choi HK, Waxman DJ. 1996 Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J Biol Chem. 271:5929–5940.[Abstract/Free Full Text]
  48. Waxman DJ, Ram PA, Park SH, Choi HK. 1995 Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. J Biol Chem. 270:13262–13270.[Abstract/Free Full Text]
  49. Lemieux S, Prud’homme D, Bouchard C, Tremblay A, Despres J-P. 1996 A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr. 64:685–693.[Abstract/Free Full Text]
  50. Bjorntorp P. 1992 Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med. 24:15–18.[Medline]
  51. Veldhuis JD, Iranmanesh A. 1996 Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. Sleep 19:S221–S224.



This article has been cited by other articles:


Home page
DiabetesHome page
J. M. Kindblom, M. Lorentzon, A. Hellqvist, L. Lonn, J. Brandberg, S. Nilsson, E. Norjavaara, and C. Ohlsson
BMI Changes During Childhood and Adolescence as Predictors of Amount of Adult Subcutaneous and Visceral Adipose Tissue in Men: The GOOD Study
Diabetes, April 1, 2009; 58(4): 867 - 874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Misra, M. A. Bredella, P. Tsai, N. Mendes, K. K. Miller, and A. Klibanski
Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E385 - E392.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Misra, J. Cord, R. Prabhakaran, K. K. Miller, and A. Klibanski
Growth Hormone Suppression after an Oral Glucose Load in Children
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4623 - 4629.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Endocr. Rev., February 1, 2005; 26(1): 114 - 146.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. L. Spadano, L. G. Bandini, A. Must, G. E. Dallal, and W. H. Dietz
Does menarche mark a period of elevated resting metabolic rate?
Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E456 - E462.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Q. He, M. Horlick, J. Thornton, J. Wang, R. N. Pierson Jr., S. Heshka, and D. Gallagher
Sex and Race Differences in Fat Distribution among Asian, African-American, and Caucasian Prepubertal Children
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2164 - 2170.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. P. Wajnrajch, J. M. Gertner, Z. Huma, J. Popovic, K. Lin, P. C. Verlander, S. D. Batish, P. F. Giampietro, J. G. Davis, M. I. New, et al.
Evaluation of Growth and Hormonal Status in Patients Referred to the International Fanconi Anemia Registry
Pediatrics, April 1, 2001; 107(4): 744 - 754.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H.-C. Lai, S. C. FitzSimmons, D. B. Allen, M. R. Kosorok, B. J. Rosenstein, P. W. Campbell, and P. M. Farrell
Risk of Persistent Growth Impairment after Alternate-Day Prednisone Treatment in Children with Cystic Fibrosis
N. Engl. J. Med., March 23, 2000; 342(12): 851 - 859.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. C. Hindmarsh, E. Dennison, S. M. Pincus, C. Cooper, C. H. D. Fall, D. R. Matthews, P. J. Pringle, and C. G. D. Brook
A Sexually Dimorphic Pattern of Growth Hormone Secretion in the Elderly
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2679 - 2685.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
A. Bitar, N. Fellmann, J. Vernet, J. Coudert, and M. Vermorel
Variations and determinants of energy expenditure as measured by whole-body indirect calorimetry during puberty and adolescence
Am. J. Clinical Nutrition, June 1, 1999; 69(6): 1209 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Giustina and J. D. Veldhuis
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human
Endocr. Rev., December 1, 1998; 19(6): 717 - 797.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roemmich, J. N.
Right arrow Articles by Rogol, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roemmich, J. N.
Right arrow Articles by Rogol, A. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals